Cardiovascular Pharmacology in Special Populations
The pharmacological management of cardiovascular diseases in special populations, such as the elderly, women, and patients with comorbid conditions, requires tailored approaches due to differences in drug metabolism, disease pathophysiology, and therapeutic responses. This session will explore the unique challenges in prescribing cardiovascular drugs for these groups, focusing on factors like polypharmacy, age-related changes in pharmacokinetics, and hormonal influences on drug efficacy and safety. Key topics will include gender differences in cardiovascular disease progression and response to treatments, the management of hypertension and heart failure in the elderly, and considerations for patients with diabetes, kidney disease, or pregnancy-related conditions. We will also discuss emerging therapies and strategies to improve cardiovascular care for underserved and high-risk populations.
Related Conference of Cardiovascular Pharmacology in Special Populations
July 21-22, 2025
11th International Conference on Antimicrobials & Antibiotic Resistance
Vancouver, Canada
August 25-26, 2025
11th International Conference on Pharmaceutical Regulatory Affairs and IPR
Vancouver, Canada
September 08-09, 2025
26th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems
Frankfurt, Germany
September 08-09, 2025
13th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Frankfurt, Germany
September 15-16, 2025
42nd International Conference on Drug Discovery and Drug delivery system
Paris, France
September 22-23, 2025
20th International Conference on Pharmaceutical Formulations & Drug Delivery
Toronto, Canada
September 23-24, 2025
10th International Conference on Future Pharma and Innovations
Amsterdam, Netherlands
November 11-12, 2025
6th Annual Congress on Antibiotics and Bacterial Infections
Amsterdam, Netherlands
November 13-14, 2025
28th International Conference and Exhibition on Pharmaceutical Formulations
Paris, France
November 13-14, 2025
21st International Conference on Pharmaceutical Chemistry
Aix-en-Provence, France
November 25-26, 2025
4th World Congress on Medicinal Chemistry and Computer Aided Drug Design
Aix-en-Provence, France
November 27-28, 2025
4th World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
December 15-16, 2025
3rd International Conference on Current Advances In Pharmaceutical Industry And development
Amsterdam, Netherlands
January 28-29, 2026
23rd International Pharmaceutical Sciences & Life Saving Drugs
Bangkok, Thailand
June 08-09, 2026
25th International Conference on Medicinal and Pharmaceutical Chemistry
San Diego, USA
June 08-09, 2026
8th International Conference and Exhibition on Pharmaceutical Development and Technology
San Diego, USA
Cardiovascular Pharmacology in Special Populations Conference Speakers
Recommended Sessions
- Advances in Cardiovascular Drug Discovery
- Biomarkers in Cardiovascular Disease and Drug Response
- Cardiac Arrhythmias and Pharmacotherapy
- Cardio protective Agents: Mechanisms and Applications
- Cardiovascular Drug Safety and Toxicology
- Cardiovascular Pharmacology in Special Populations
- Drug Repurposing in Cardiovascular Medicine
- Emerging Antithrombotic Therapies
- Endothelial Nitric Oxide and Cardiovascular Health
- Innovations in Heart Failure Pharmacotherapy
- Lipids and Cholesterol Management in Cardiovascular Disease
- Molecular Mechanisms of Cardiovascular Pharmacology
- Nanomedicine in Cardiovascular Pharmacology
- Novel Targets in Hypertension Therapy
- Personalized Medicine in Cardiovascular Care
- Pharmacogenomics in Cardiovascular Medicine
- Pharmacokinetics and Pharmacodynamics in Cardiology
- Pharmacological Approaches to Myocardial Ischemia
- Pharmacological Management of Cardiovascular Risk Factors
- Role of Gut Microbiome in Cardiovascular Health
- Role of Inflammation in Cardiovascular Diseases
- Targeted Therapies in Cardiovascular Regeneration
- Targeting the Renin-Angiotensin-Aldosterone System (RAAS)
- Vascular Pharmacology: Focus on Endothelial Dysfunction
Related Journals
Are you interested in
- 3D Bioprinting and Organ-on-a-Chip Models - Drug Delivery-2025 (France)
- 3D Printing in Drug Formulation - Drug Delivery-2025 (Netherlands)
- Accelerating Orphan Drug Access and Innovation Worldwide - ORPHAN DRUGS 2025 (France)
- Active Pharmaceutical Ingredients - MedTech-2025 (Switzerland)
- Acupuncture - Naturalproducts 2025 (Germany)
- Adaptive Trial Models in Research - Clinical Trials Congress-2025 (France)
- Advanced Analytical Techniques - Biologics Meet 2026 (UK)
- Advanced Analytical Techniques in Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Advanced Drug Delivery Systems - Drug Delivery-2025 (Netherlands)
- Advanced Drug Discovery & Development - Pharma Expo-2026 (Thailand)
- Advancements in Pharmacovigilance - Clinical Trials Congress-2025 (France)
- Advances in Cardiovascular Drug Discovery - Cardiovascular-2025 (France)
- Advances in Drug Discovery - Clinical Trials Congress-2025 (France)
- Advances in Medicinal Chemistry: From Bench to Bedside - Euro MedChem and CADD 2025 (France)
- AI & Digital Tools in Formulation and Delivery Design - Drug Delivery-2025 (Netherlands)
- AI & Machine Learning in Biologics - Biologics Meet 2026 (UK)
- AI & Machine Learning in Drug Discovery - Euro MedChem and CADD 2025 (France)
- AI and Machine Learning in Antimicrobial Research - Euro Antibiotics 2025 (Netherlands)
- AI and Machine Learning in Rare Disease Diagnosis - ORPHAN DRUGS 2025 (France)
- Alternative Medicine and Complementary Medicine - Naturalproducts 2025 (Germany)
- Analytical strategies for pharmaceutical products - MedTech-2025 (Switzerland)
- Anti-Microbial Resistance & Infectious Diseases - Pharma Expo-2026 (Thailand)
- Antibiotic Challenges in Pediatric and Geriatric Populations - Euro Antibiotics 2025 (Netherlands)
- Antibiotic Prophylaxis - Antibiotics Resistance 2025 (Canada)
- Antibiotic Resistance and Drug-Resistant Pathogens - Euro Pharmacology 2025 (France)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics Resistance 2025 (Canada)
- Antibiotic Use in Agriculture and Food Chain Safety - Euro Antibiotics 2025 (Netherlands)
- Antibiotic-resistant Bacterial infections - Antibiotics Resistance 2025 (Canada)
- Antibiotics - Antibiotics Resistance 2025 (Canada)
- Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2025 (Canada)
- Antibiotics: In Pregnancy and Lactation - Antibiotics Resistance 2025 (Canada)
- Antimicrobial Peptides - Antibiotics Resistance 2025 (Canada)
- Antimicrobial Peptides and Host Defense Molecules - Euro Antibiotics 2025 (Netherlands)
- Antimicrobial Resistance and Novel Therapeutics - Drug Delivery-2025 (France)
- Antimicrobial Therapies - Antibiotics Resistance 2025 (Canada)
- Artificial Intelligence (AI) - Personalizedmedicine-2025 (Switzerland)
- Artificial Intelligence and Big Data in Pharma - Pharma Expo-2026 (Thailand)
- Artificial Intelligence and Machine Learning in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Artificial Intelligence in Drug Discovery - Drug Delivery-2025 (France)
- Bacterial Genomics and Resistance Gene Transfer - Euro Antibiotics 2025 (Netherlands)
- Be Part of the Rare Disease Movement in Paris - ORPHAN DRUGS 2025 (France)
- Big data analytics and Pharma - Future Pharma 2025 (Netherlands)
- Bio-Pharmaceutics - PHARMACEUTICA 2025 (Germany)
- Bioequivalence and Bioavailability - MedTech-2025 (Switzerland)
- Biofilms and Chronic Infections - Euro Antibiotics 2025 (Netherlands)
- Bioinformatics Driving Precision in Rare Disease Research - ORPHAN DRUGS 2025 (France)
- Biologics & Biosimilars - PHARMACEUTICA 2025 (Germany)
- Biologics and Biosimilar Development - Drug Delivery-2025 (France)
- Biologics and Biosimilars - Pharmacology-2025 (Spain)
- Biologics Innovation & Design - Biologics Meet 2026 (UK)
- Biomanufacturing & Process Optimization - Biologics Meet 2026 (UK)
- Biomarker Discovery in Drug Development - Clinical Trials Congress-2025 (France)
- Biomarkers - Personalizedmedicine-2025 (Switzerland)
- Biomarkers in Cardiovascular Disease and Drug Response - Cardiovascular-2025 (France)
- Biomaterials in Drug Delivery - PHARMACEUTICA 2025 (Germany)
- Biopharmaceuticals and Biotechnology - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Biopharmaceutics & Biotherapeutics - Drug Delivery-2025 (Netherlands)
- Biosimilar Interchangeability & Substitution - Biologics Meet 2026 (UK)
- Biosimilars and Biobetters - Pharma Expo-2026 (Thailand)
- Biosimilars in Oncology & Autoimmune Disorders - Biologics Meet 2026 (UK)
- Biosimilars: Market Access & Adoption - Biologics Meet 2026 (UK)
- Cancer Clinical Research Progress - Clinical Trials Congress-2025 (France)
- Cancer Pharmacology and Chemotherapeutics - Euro Pharmacology 2025 (France)
- Cardiac Arrhythmias and Pharmacotherapy - Cardiovascular-2025 (France)
- Cardio protective Agents: Mechanisms and Applications - Cardiovascular-2025 (France)
- Cardiovascular and Renal Pharmacology - Pharmacology-2025 (Spain)
- Cardiovascular Drug Safety and Toxicology - Cardiovascular-2025 (France)
- Cardiovascular Pharmacology in Special Populations - Cardiovascular-2025 (France)
- Career Development & Innovation in Pharma - Pharma Expo-2026 (Thailand)
- Case Studies in Drug Discovery and Development - Euro MedChem and CADD 2025 (France)
- Challenges and Future Innovations of Traditional Medicine - Naturalproducts 2025 (Germany)
- Challenges in Drug Formulation and Stability - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Cheminformatics and Big Data in Drug Design - Euro MedChem and CADD 2025 (France)
- Clinical and Hospital Pharmacy - Future Pharma 2025 (Netherlands)
- Clinical and Translational Pharmacology - Pharmacology-2025 (Spain)
- Clinical Data & Analytics Strategies - Clinical Trials Congress-2025 (France)
- Clinical Pharmacology & Receptor Therapy - Clinical Trials Congress-2025 (France)
- Clinical Pharmacology and Therapeutics - Euro Pharmacology 2025 (France)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2025 (Switzerland)
- Clinical Research and Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Clinical Trial Auditing Innovations - Clinical Trials Congress-2025 (France)
- Clinical Trial Efficiency Factors - Clinical Trials Congress-2025 (France)
- Clinical Trials - Clinical Trials Congress-2025 (France)
- Clinical Trials - Personalizedmedicine-2025 (Switzerland)
- Clinical Trials & Case Studies in Drug Delivery - Drug Delivery-2025 (Netherlands)
- Clinical Trials & Real-World Evidence - Biologics Meet 2026 (UK)
- Clinical Trials & Regulatory Affairs - Pharma Expo-2026 (Thailand)
- Clinical Trials & Safety Monitoring - Clinical Trials Congress-2025 (France)
- Clinical trials and Pharmacovigilance - MedTech-2025 (Switzerland)
- Clinical Trials and Real-World Evidence - Pharmacology-2025 (Spain)
- Cloud Computing and Open Science Platforms in CADD - Euro MedChem and CADD 2025 (France)
- Co-Infections and Polymicrobial Disease Mechanisms - Euro Antibiotics 2025 (Netherlands)
- Computational Approaches for Target Identification and Validation - Euro MedChem and CADD 2025 (France)
- Computational Chemistry and Molecular Modeling - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Computational Drug Discovery and Design - Euro MedChem and CADD 2025 (France)
- Controlled and Sustained Drug Release Systems - Drug Delivery-2025 (France)
- Controlled and Targeted Drug Delivery - Drug Delivery-2025 (Netherlands)
- CRISPR and Gene Editing Drug Technologies - Drug Delivery-2025 (France)
- Cross-Border Collaborations Fuel Rare Disease Research - ORPHAN DRUGS 2025 (France)
- Crude Drugs and Plant Products - Naturalproducts 2025 (Germany)
- Current Research in Antibiotic Resistance - Antibiotics Resistance 2025 (Canada)
- Cutting-edge Imaging Research - Clinical Trials Congress-2025 (France)
- Data Analytics - Personalizedmedicine-2025 (Switzerland)
- Decentralized Clinical Trials: Future of Rare Disease R&D - ORPHAN DRUGS 2025 (France)
- Decentralized Trial Models - Clinical Trials Congress-2025 (France)
- Developing Alternatives to Antibiotics - Antibiotics Resistance 2025 (Canada)
- Digital Health - Personalizedmedicine-2025 (Switzerland)
- Digital Marketing in Pharma Industry - Future Pharma 2025 (Netherlands)
- Digital Therapeutics and Smart Drug Delivery Devices - Drug Delivery-2025 (France)
- Digital Transformation in Biologics - Biologics Meet 2026 (UK)
- Disease Prevention - Personalizedmedicine-2025 (Switzerland)
- Drug Delivery & Blood-Brain Barrier - Clinical Trials Congress-2025 (France)
- Drug Delivery Across the Blood-Brain Barrier - Drug Delivery-2025 (Netherlands)
- Drug Delivery in Oncology and Immunotherapy - Drug Delivery-2025 (Netherlands)
- Drug Design and Development - Formulations 2025 (France)
- Drug Discovery and Development - Future Pharma 2025 (Netherlands)
- Drug Discovery and Development - Pharmacology-2025 (Spain)
- Drug discovery and NCEs - MedTech-2025 (Switzerland)
- Drug Discovery and Novel Delivery Technologies - Antibiotics Resistance 2025 (Canada)
- Drug Discovery, Design, and Development - Euro Pharmacology 2025 (France)
- Drug Formulation for Rare & Orphan Diseases - Drug Delivery-2025 (Netherlands)
- Drug Formulation Procedures - Formulations 2025 (France)
- Drug Product Manufacturing - Formulations 2025 (France)
- Drug Repurposing and Computational Drug Design - Drug Delivery-2025 (France)
- Drug Repurposing and Orphan Drugs - Pharma Expo-2026 (Thailand)
- Drug Repurposing in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Drug Targeting and Design - PHARMACEUTICA 2025 (Germany)
- Electronic Health Records (EHRs) - Personalizedmedicine-2025 (Switzerland)
- Emergency Preparedness for Outbreaks and Bacterial Pandemics - Euro Antibiotics 2025 (Netherlands)
- Emerging Antithrombotic Therapies - Cardiovascular-2025 (France)
- Emerging Technologies in Pharmaceutical Sciences - Pharma Expo-2026 (Thailand)
- Emerging Therapeutic Modalities - Pharmacology-2025 (Spain)
- Empowering Rare Disease Patients Through Advocacy - ORPHAN DRUGS 2025 (France)
- Endocrine Disruptors and Reproductive Toxicology - Euro Pharmacology 2025 (France)
- Endothelial Nitric Oxide and Cardiovascular Health - Cardiovascular-2025 (France)
- Environmental and Occupational Toxicology - Euro Pharmacology 2025 (France)
- Ethical Frameworks in Rare Disease Drug Development - ORPHAN DRUGS 2025 (France)
- Ethics, Policy & Global Access to Medicines - Pharma Expo-2026 (Thailand)
- Ethnopharmacology - Pharmacology-2025 (Spain)
- Exosome-Based Drug Delivery - Drug Delivery-2025 (France)
- Formulations and NNDS - MedTech-2025 (Switzerland)
- Fragment-Based and Ligand-Based Design - Euro MedChem and CADD 2025 (France)
- Future of Biologics: Gene & Cell Therapy Integration - Biologics Meet 2026 (UK)
- Gaseous Dosage Forms - Formulations 2025 (France)
- Gene Therapy Revolution: A Focus at Rare Disease Congress - ORPHAN DRUGS 2025 (France)
- General Considerations in Dosage Forms - Formulations 2025 (France)
- Genetic Testing - Personalizedmedicine-2025 (Switzerland)
- Genomics - Personalizedmedicine-2025 (Switzerland)
- Global Biosimilars Market Trends - Biologics Meet 2026 (UK)
- Global Experts Gather for Rare Disease Breakthroughs in Paris - ORPHAN DRUGS 2025 (France)
- Global Policy Dialogues on Orphan Drug Legislation - ORPHAN DRUGS 2025 (France)
- Green & Sustainable Pharmaceutical Manufacturing - Drug Delivery-2025 (Netherlands)
- Green and Community Pharmacy - Future Pharma 2025 (Netherlands)
- Green Chemistry in Drug Synthesis - Drug Delivery-2025 (France)
- Green Chemistry in Pharmaceutical Development - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Health Equity - Personalizedmedicine-2025 (Switzerland)
- Herbal Medicine - Naturalproducts 2025 (Germany)
- Hereditary Angioedema Research - Clinical Trials Congress-2025 (France)
- Holistic Approaches to Rare Disease Patient Care - ORPHAN DRUGS 2025 (France)
- Homeopathic and Ayurvedic Medicines - Naturalproducts 2025 (Germany)
- Immune Response and Host–Pathogen Dynamics - Euro Antibiotics 2025 (Netherlands)
- Immunogenicity: Risk & Regulation - Biologics Meet 2026 (UK)
- Immunology & Vaccines - Antibiotics Resistance 2025 (Canada)
- Immunopharmacology and Inflammation - Pharmacology-2025 (Spain)
- Immunopharmacology and Vaccine Development - Euro Pharmacology 2025 (France)
- Immunotherapy and Vaccine Delivery Innovations - Drug Delivery-2025 (France)
- In Silico ADME-Tox Prediction and Optimization - Euro MedChem and CADD 2025 (France)
- Inclusive Clinical Trials for Rare Disease Diversity - ORPHAN DRUGS 2025 (France)
- Industrial and Regulatory Toxicology - Euro Pharmacology 2025 (France)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2025 (Netherlands)
- Infection Control in Healthcare Settings - Euro Antibiotics 2025 (Netherlands)
- Infectious Disease Epidemiology and Global Surveillance - Euro Antibiotics 2025 (Netherlands)
- Infectious Diseases - Antibiotics Resistance 2025 (Canada)
- Inhalable and Transdermal Drug Delivery - Drug Delivery-2025 (France)
- Inhalation and Nasal Drug Delivery - Drug Delivery-2025 (Netherlands)
- Injectable & Implantable Drug Delivery - Drug Delivery-2025 (Netherlands)
- Innovations in Drug Formulation - Drug Delivery-2025 (Netherlands)
- Innovations in Heart Failure Pharmacotherapy - Cardiovascular-2025 (France)
- Innovations in Molecular Visualization and Virtual Reality Tools - Euro MedChem and CADD 2025 (France)
- Innovative Diagnostics for Rare Genetic Conditions - ORPHAN DRUGS 2025 (France)
- Innovative Drug Design and Discovery - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Life-Saving Drugs: Innovation and Impact - Pharma Expo-2026 (Thailand)
- Lifestyle Medicine - Personalizedmedicine-2025 (Switzerland)
- Ligand-Based Drug Design and Virtual Screening - Euro MedChem and CADD 2025 (France)
- Lipids and Cholesterol Management in Cardiovascular Disease - Cardiovascular-2025 (France)
- Liposomes, Microspheres & Hydrogels - Drug Delivery-2025 (Netherlands)
- Liquid Dosage Forms - Formulations 2025 (France)
- Long-Acting Injectable and Depot Formulations - Drug Delivery-2025 (France)
- Marine Natural Products - Naturalproducts 2025 (Germany)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics Resistance 2025 (Canada)
- Mechanisms of Antimicrobial Resistance - Euro Antibiotics 2025 (Netherlands)
- Medical Devices for Drug Delivery - PHARMACEUTICA 2025 (Germany)
- Medicinal Chemistry - Naturalproducts 2025 (Germany)
- Medicinal Chemistry and Targeted Therapies - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Medicinal Plant Research - Naturalproducts 2025 (Germany)
- Medicinal Plants as Anti-Cancer Drugs - Naturalproducts 2025 (Germany)
- Mental Health and Rare Disease: An Urgent Priority - ORPHAN DRUGS 2025 (France)
- Micro Organisms in Recent Drug Discovery - Antibiotics Resistance 2025 (Canada)
- Microbiota-Based Therapies and Infection Prevention - Euro Antibiotics 2025 (Netherlands)
- Microorganisms Producing Antibiotics - Antibiotics Resistance 2025 (Canada)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2025 (Canada)
- Modern Strategies in Lead Identification and Optimization - Euro MedChem and CADD 2025 (France)
- Molecular and Cellular Pharmacology - Pharmacology-2025 (Spain)
- Molecular and Cellular Pharmacology - Euro Pharmacology 2025 (France)
- Molecular Dynamics and Free Energy Calculations - Euro MedChem and CADD 2025 (France)
- Molecular Mechanisms of Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Monoclonal Antibodies & Therapeutics - Biologics Meet 2026 (UK)
- mRNA and Nucleic Acid Delivery Systems - Drug Delivery-2025 (France)
- Multidrug-Resistant Pathogens: Clinical Impact and Solutions - Euro Antibiotics 2025 (Netherlands)
- Nano particulate Drug Delivery Systems - PHARMACEUTICA 2025 (Germany)
- Nanomedicine and Biomedical Applications - PHARMACEUTICA 2025 (Germany)
- Nanomedicine in Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Nanotechnology in Drug Delivery - Drug Delivery-2025 (France)
- Nanotechnology in Drug Delivery - Pharma Expo-2026 (Thailand)
- Nanotechnology in Drug Delivery - Drug Delivery-2025 (Netherlands)
- Nanotechnology in Drug Delivery Systems - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Nanotechnology in Drug Discovery - Clinical Trials Congress-2025 (France)
- Nanotoxicology and Nanomedicine in Drug Delivery - Euro Pharmacology 2025 (France)
- Natural Product Pharmacology - Pharmacology-2025 (Spain)
- Natural Products - Naturalproducts 2025 (Germany)
- Natural Products & Phytopharmaceuticals - Pharma Expo-2026 (Thailand)
- Natural Products and Herbal Medicine Pharmacology - Euro Pharmacology 2025 (France)
- Natural Products Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Natural Products Chemistry - Naturalproducts 2025 (Germany)
- Neuropharmacology and CNS Drug Design - Euro MedChem and CADD 2025 (France)
- Neuropharmacology and CNS Drug Research - Euro Pharmacology 2025 (France)
- Neuropharmacology and Psychopharmacology - Pharmacology-2025 (Spain)
- New antibiotics and non-antibiotic approaches - Antibiotics Resistance 2025 (Canada)
- New Sources and Approaches to Natural Products - Naturalproducts 2025 (Germany)
- Next-Gen Biosimilars & Pipeline Trends - Biologics Meet 2026 (UK)
- Next-Gen Drug Design Techniques - Clinical Trials Congress-2025 (France)
- Next-Generation Antibiotics and Drug Design - Euro Antibiotics 2025 (Netherlands)
- Novel Drug Delivery Systems - Future Pharma 2025 (Netherlands)
- Novel Drug Delivery Systems - Formulations 2025 (France)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2025 (Switzerland)
- Novel Targets in Hypertension Therapy - Cardiovascular-2025 (France)
- Nutraceuticals & Functional Medicine - Naturalproducts 2025 (Germany)
- Ocular Drug Delivery - Drug Delivery-2025 (Netherlands)
- One Health: Environmental and Zoonotic Perspectives on AMR - Euro Antibiotics 2025 (Netherlands)
- Oral Drug Delivery & Solid Dosage Forms - Drug Delivery-2025 (Netherlands)
- Organic Chemistry in Pharmaceuticals - Clinical Trials Congress-2025 (France)
- Orphan Drug Economics and Market Trends in 2025 - ORPHAN DRUGS 2025 (France)
- Overcoming the Blood-Brain Barrier - Drug Delivery-2025 (France)
- Patient Registries: Building Rare Disease Knowledge Globally - ORPHAN DRUGS 2025 (France)
- Patient-Cantered Care - Personalizedmedicine-2025 (Switzerland)
- Patient-Centric Biologic Therapies - Biologics Meet 2026 (UK)
- Patient-Centric Innovation in Orphan Drug Development - ORPHAN DRUGS 2025 (France)
- Pediatric and Geriatric Pharmacology - Pharmacology-2025 (Spain)
- Pediatric and Geriatric Pharmacology - Pharma Expo-2026 (Thailand)
- Pediatric Rare Diseases: Global Focus at Paris 2025 - ORPHAN DRUGS 2025 (France)
- Peptide and Macrocycle Drug Design - Euro MedChem and CADD 2025 (France)
- Peptide and Nucleic Acid Therapeutics - Euro MedChem and CADD 2025 (France)
- Peptide and Protein Drug Delivery - Drug Delivery-2025 (Netherlands)
- Personalized & Precision Medicine - Drug Delivery-2025 (Netherlands)
- Personalized and Precision Medicine - Pharma Expo-2026 (Thailand)
- Personalized Healthcare - Personalizedmedicine-2025 (Switzerland)
- Personalized Medicine in Cardiovascular Care - Cardiovascular-2025 (France)
- Phage Therapy and Bacteriophage Applications - Euro Antibiotics 2025 (Netherlands)
- Pharma and Biotech Financial Outlook - Future Pharma 2025 (Netherlands)
- Pharma Market Research - MedTech-2025 (Switzerland)
- Pharmaceutical Analysis - Future Pharma 2025 (Netherlands)
- Pharmaceutical Analysis - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Analysis - Formulations 2025 (France)
- Pharmaceutical and healthcare Industry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Biotechnology and Biologics - Pharma Expo-2026 (Thailand)
- Pharmaceutical Chemistry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Chemistry - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Excipients - Formulations 2025 (France)
- Pharmaceutical Formulation - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Formulation - Formulations 2025 (France)
- Pharmaceutical Formulation & Drug Delivery Systems - Pharma Expo-2026 (Thailand)
- Pharmaceutical Formulation Advances - Clinical Trials Congress-2025 (France)
- Pharmaceutical Industry and Market Trends - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Pharmaceutical Manufacturing - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2025 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2025 (Switzerland)
- Pharmaceutical Nanotechnology - PHARMACEUTICA 2025 (Germany)
- Pharmaceutical Nanotechnology - Pharmacology-2025 (Spain)
- Pharmaceutical Packaging and Logistics - MedTech-2025 (Switzerland)
- Pharmaceutical Preformulation Studies - Drug Delivery-2025 (Netherlands)
- Pharmaceutical Quality Assurance and GMP - Pharma Expo-2026 (Thailand)
- Pharmaceutical Sciences - MedTech-2025 (Switzerland)
- Pharmaceutical Supply Chain & Logistics - Pharma Expo-2026 (Thailand)
- Pharmaceutical Technology - Clinical Trials Congress-2025 (France)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2025 (Netherlands)
- Pharmacoeconomics - MedTech-2025 (Switzerland)
- Pharmacogenetics - Personalizedmedicine-2025 (Switzerland)
- Pharmacogenomics - Personalizedmedicine-2025 (Switzerland)
- Pharmacogenomics and Personalized Medicine - Euro Pharmacology 2025 (France)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2025 (Switzerland)
- Pharmacogenomics and Precision Medicine - Pharmacology-2025 (Spain)
- Pharmacogenomics in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Pharmacokinetics and Drug Metabolism Modeling - Drug Delivery-2025 (France)
- Pharmacokinetics and Drug Optimization Strategies - Euro Antibiotics 2025 (Netherlands)
- Pharmacokinetics and Pharmacodynamics - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmacology-2025 (Spain)
- Pharmacokinetics and Pharmacodynamics - Euro Pharmacology 2025 (France)
- Pharmacokinetics and Pharmacodynamics - Drug Delivery-2025 (Netherlands)
- Pharmacokinetics and Pharmacodynamics in Cardiology - Cardiovascular-2025 (France)
- Pharmacokinetics and Pharmacodynamics in Drugs - PHARMACEUTICA 2025 (Germany)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics Resistance 2025 (Canada)
- Pharmacological Approaches to Myocardial Ischemia - Cardiovascular-2025 (France)
- Pharmacological Interventions in Mental Health - Euro Pharmacology 2025 (France)
- Pharmacological Management of Cardiovascular Risk Factors - Cardiovascular-2025 (France)
- Pharmacology & Toxicology - Antibiotics Resistance 2025 (Canada)
- Pharmacology and Toxicology - MedTech-2025 (Switzerland)
- Pharmacology in Public Health - Pharmacology-2025 (Spain)
- Pharmacovigilance & Drug Safety - Pharma Expo-2026 (Thailand)
- Pharmacovigilance & Post-Marketing Safety - Biologics Meet 2026 (UK)
- Pharmacovigilance and Drug Safety - Pharmacology-2025 (Spain)
- Phytochemistry - Naturalproducts 2025 (Germany)
- Population Health - Personalizedmedicine-2025 (Switzerland)
- Post-Marketing Surveillance Insights - Clinical Trials Congress-2025 (France)
- Post-Trial Closed Communities - Clinical Trials Congress-2025 (France)
- Precision Medicine - Personalizedmedicine-2025 (Switzerland)
- QC & QA: Quality control and Quality assurance - MedTech-2025 (Switzerland)
- Quality by design (QbD) approach - MedTech-2025 (Switzerland)
- Quantum Chemistry and Molecular Simulations - Euro MedChem and CADD 2025 (France)
- Rapid Diagnostic Tools in Clinical Microbiology - Euro Antibiotics 2025 (Netherlands)
- Rare Cancers: Spotlight on Precision Oncology - ORPHAN DRUGS 2025 (France)
- Rare Disease Startups: Innovation and Investment Insights - ORPHAN DRUGS 2025 (France)
- Rare Neurological Disorders Take Center Stage - ORPHAN DRUGS 2025 (France)
- Regulatory Affairs & Global Approval - Biologics Meet 2026 (UK)
- Regulatory Affairs and Drug Approval - Pharmacology-2025 (Spain)
- Regulatory Affairs and Drug Safety - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2025 (Netherlands)
- Regulatory Affairs and Quality Assurance - Drug Delivery-2025 (Netherlands)
- Regulatory Authority Compliance - MedTech-2025 (Switzerland)
- Regulatory Harmonization & Compliance - Biologics Meet 2026 (UK)
- Regulatory Science and Clinical Trial Innovations - Euro Antibiotics 2025 (Netherlands)
- Regulatory Science and Translational Medicine - Drug Delivery-2025 (France)
- Role of Gut Microbiome in Cardiovascular Health - Cardiovascular-2025 (France)
- Role of Inflammation in Cardiovascular Diseases - Cardiovascular-2025 (France)
- Semi-Solid Dosage Forms - Formulations 2025 (France)
- Sexually Transmitted Bacterial Infections and Resistance Trends - Euro Antibiotics 2025 (Netherlands)
- Single-Use Technologies in Production - Biologics Meet 2026 (UK)
- Smart Drug Delivery Systems - PHARMACEUTICA 2025 (Germany)
- Smart Drug Delivery Systems - Formulations 2025 (France)
- Smart Polymers and Biomaterials - Drug Delivery-2025 (Netherlands)
- Smart Polymers and Responsive Drug Carriers - Drug Delivery-2025 (France)
- Solid Dosage Forms - Formulations 2025 (France)
- Stewardship Programs in Human and Animal Health - Euro Antibiotics 2025 (Netherlands)
- Structure-Based Drug Design and Molecular Docking - Euro MedChem and CADD 2025 (France)
- Sustainable Antibiotic Practices and Global Policy - Euro Antibiotics 2025 (Netherlands)
- Sustainable Biologics Manufacturing - Biologics Meet 2026 (UK)
- Synthetic and Bioorganic Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (France)
- Synthetic and Green Medicinal Chemistry - Euro MedChem and CADD 2025 (France)
- Systems Pharmacology and Drug Modeling - Euro Pharmacology 2025 (France)
- Target Identification and Validation - Euro MedChem and CADD 2025 (France)
- Targeted Drug Delivery and Nanomedicine in Infectious Diseases - Euro Antibiotics 2025 (Netherlands)
- Targeted Drug Delivery and Precision Medicine - Drug Delivery-2025 (France)
- Targeted Therapies - Personalizedmedicine-2025 (Switzerland)
- Targeted Therapies in Cardiovascular Regeneration - Cardiovascular-2025 (France)
- Targeting the Renin-Angiotensin-Aldosterone System (RAAS) - Cardiovascular-2025 (France)
- Technology in Pharma Sciences - MedTech-2025 (Switzerland)
- Telemedicine - Personalizedmedicine-2025 (Switzerland)
- The Future of Pharma R&D - Future Pharma 2025 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics Resistance 2025 (Canada)
- Toxicological Impacts of Air and Water Pollution - Euro Pharmacology 2025 (France)
- Toxicology and Safety Pharmacology - Pharmacology-2025 (Spain)
- Toxicology: Mechanisms and Risk Assessment - Euro Pharmacology 2025 (France)
- Transdermal and Intradermal Delivery Systems - Drug Delivery-2025 (Netherlands)
- Translational Research - Personalizedmedicine-2025 (Switzerland)
- Trending: Digital Health and Telemedicine for Rare Care - ORPHAN DRUGS 2025 (France)
- Types of Formulations - Formulations 2025 (France)
- Vaccine Delivery Technologies - Drug Delivery-2025 (Netherlands)
- Vaccine Development Against Bacterial Pathogens - Euro Antibiotics 2025 (Netherlands)
- Vaccine Drug Delivery Systems - PHARMACEUTICA 2025 (Germany)
- Vaccines & Immunotherapy - Pharma Expo-2026 (Thailand)
- Vascular Pharmacology: Focus on Endothelial Dysfunction - Cardiovascular-2025 (France)
- Veterinary Pharmacology - Pharmacology-2025 (Spain)
- Women in Rare Disease Leadership and Science - ORPHAN DRUGS 2025 (France)